Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 330

1.
2.

Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system.

Weber WA, Neverve J, Sklarek J, Ziegler SI, Bartenstein P, King B, Treumann T, Enterrottacher A, Krapf M, Häussinger KE, Lichte H, Präuer HW, Thetter O, Schwaiger M.

Eur J Nucl Med. 1999 Apr;26(4):388-95.

PMID:
10199945
4.

F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.

Zimny M, Kaiser HJ, Cremerius U, Sabri O, Schreckenberger M, Reinartz P, Büll U.

Nuklearmedizin. 1999;38(4):108-14.

PMID:
10392375
6.

Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection.

Zimny M, Kaiser HJ, Cremerius U, Reinartz P, Schreckenberger M, Sabri O, Buell U.

Eur J Nucl Med. 1999 Aug;26(8):818-23.

PMID:
10436193
7.

FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET.

Coleman RE, Laymon CM, Turkington TG.

Radiology. 1999 Mar;210(3):823-8.

PMID:
10207487
9.
10.

Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera.

Zimny M, Hochstenbag M, Lamers R, Reinartz P, Cremerius U, ten Velde G, Buell U.

Eur Radiol. 2003 Apr;13(4):740-7. Epub 2002 Sep 7.

PMID:
12664112
11.

Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.

Higashi K, Nishikawa T, Seki H, Oguchi M, Nambu Y, Ueda Y, Yuasa K, Tonami H, Okimura T, Yamamoto I.

J Nucl Med. 1998 Jan;39(1):9-15.

13.
14.

Diagnosis of myocardial viability by dual-head coincidence gamma camera fluorine-18 fluorodeoxyglucose positron emission tomography with and without non-uniform attenuation correction.

Nowak B, Zimny M, Schwarz ER, Kaiser HJ, Schaefer W, Reinartz P, vom Dahl J, Buell U.

Eur J Nucl Med. 2000 Oct;27(10):1501-8.

PMID:
11083539
15.

Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET.

Tatsumi M, Yutani K, Watanabe Y, Miyoshi S, Tomiyama N, Johkoh T, Kusuoka H, Nakamura H, Nishimura T.

J Nucl Med. 1999 Apr;40(4):566-73.

16.

The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.

Eschmann SM, Bitzer M, Paulsen F, Friedel G, Besenfelder H, Horger M, Reimold M, Dittmann H, Pfannenberg AC, Bares R.

Nucl Med Commun. 2004 Sep;25(9):909-15.

PMID:
15319596
17.
18.

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M.

J Natl Cancer Inst. 1996 Sep 4;88(17):1204-9.

PMID:
8780629
19.

Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology.

Gerbaudo VH, Sugarbaker DJ, Britz-Cunningham S, Di Carli MF, Mauceri C, Treves ST.

J Nucl Med. 2002 Sep;43(9):1144-9.

20.

Diagnosis of spine metastases by FDG imaging using a gamma camera in the coincidence mode.

Shreve PD, Steventon RS, Gross MD.

Clin Nucl Med. 1998 Dec;23(12):799-802.

PMID:
9858288

Supplemental Content

Support Center